News
IPST celebrates scientific discoveries
Let’s talk
At IPST we believe each study is worthy of tailored protocols designed to maximize the scientific and strategic value of the data generated. We believe in taking ownership of the studies entrusted to IPST while ensuring mutual collaboration for developing and agreeing to overall project plans.
Contact us
Our expertise
Established in 1999, we have conducted thousands of preclinical cardiac safety and efficacy studies and GLP-compliant studies in support of FDA, EMEA, Health Canada and MoHW requirements.
Learn more